HK1177452A1 - Fluoro-substituted 2-aryl-3,5-dicyano-4-indazolyl-6-methyl-1,4- dihydropyridines and uses thereof 2--3,5--4--6--1,4- - Google Patents

Fluoro-substituted 2-aryl-3,5-dicyano-4-indazolyl-6-methyl-1,4- dihydropyridines and uses thereof 2--3,5--4--6--1,4-

Info

Publication number
HK1177452A1
HK1177452A1 HK13102938.6A HK13102938A HK1177452A1 HK 1177452 A1 HK1177452 A1 HK 1177452A1 HK 13102938 A HK13102938 A HK 13102938A HK 1177452 A1 HK1177452 A1 HK 1177452A1
Authority
HK
Hong Kong
Prior art keywords
dihydropyridines
dicyano
indazolyl
fluoro
aryl
Prior art date
Application number
HK13102938.6A
Other languages
English (en)
Chinese (zh)
Inventor
Alexandros Vakalopoulos
Martin Michels
Katja Zimmermann
Nicole Teusch
Mario Lobell
Karen Engel
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of HK1177452A1 publication Critical patent/HK1177452A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK13102938.6A 2009-11-11 2013-03-08 Fluoro-substituted 2-aryl-3,5-dicyano-4-indazolyl-6-methyl-1,4- dihydropyridines and uses thereof 2--3,5--4--6--1,4- HK1177452A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09175642 2009-11-11
PCT/EP2010/066983 WO2011069761A1 (en) 2009-11-11 2010-11-08 Fluoro-substituted 2-aryl-3,5-dicyano-4-indazolyl-6-methyl-1,4-dihydropyridines and uses thereof

Publications (1)

Publication Number Publication Date
HK1177452A1 true HK1177452A1 (en) 2013-08-23

Family

ID=43629143

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13102938.6A HK1177452A1 (en) 2009-11-11 2013-03-08 Fluoro-substituted 2-aryl-3,5-dicyano-4-indazolyl-6-methyl-1,4- dihydropyridines and uses thereof 2--3,5--4--6--1,4-

Country Status (8)

Country Link
US (1) US9018234B2 (ja)
EP (1) EP2499124B1 (ja)
JP (1) JP5753182B2 (ja)
CN (1) CN102666525B (ja)
CA (1) CA2777907C (ja)
ES (1) ES2549132T3 (ja)
HK (1) HK1177452A1 (ja)
WO (1) WO2011069761A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104513253A (zh) 2013-10-01 2015-04-15 南京波尔泰药业科技有限公司 用于治疗增殖性疾病的大环化合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3635977A (en) 1969-11-03 1972-01-18 American Cyanamid Co Certain 6-trifluoromethylcytosines and thiocytosines their synthesis and their use in the synthesis of uracisls and thiouracil
EP1720855A4 (en) 2004-03-02 2008-12-17 Smithkline Beecham Corp HEMMER OF ACT ACTIVITY
CA2589777A1 (en) 2004-12-13 2006-06-22 Irm Llc Compounds and compositions as modulators of steroidal receptors and calcium channel activities
CA2603676A1 (en) 2005-01-07 2006-07-13 Roskamp Research Llc Compounds for inhibiting beta-amyloid production and methods of identifying the compounds
CL2007003609A1 (es) 2006-12-14 2008-07-25 Bayer Schering Pharma Ag Compuestos derivados de dihidropiridinas sustituidas; proceso de preparacion; compuestos intermediarios; composicion farmaceutica; proceso para producir la composicion farmaceutica; y uso en el tratamiento de una enfermedad mejorada con la inhibicion

Also Published As

Publication number Publication date
CA2777907A1 (en) 2011-06-16
CA2777907C (en) 2017-08-29
CN102666525B (zh) 2015-01-28
US20130005773A1 (en) 2013-01-03
ES2549132T3 (es) 2015-10-23
EP2499124B1 (en) 2015-08-19
JP5753182B2 (ja) 2015-07-22
WO2011069761A1 (en) 2011-06-16
US9018234B2 (en) 2015-04-28
JP2013510814A (ja) 2013-03-28
CN102666525A (zh) 2012-09-12
EP2499124A1 (en) 2012-09-19

Similar Documents

Publication Publication Date Title
IL243932A0 (en) Certain chemical entities, preparations and methods
HK1199031A1 (en) Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof 2--5--1,2,4-
GB0917044D0 (en) Agents, uses and methods
GB0917054D0 (en) Agents, uses and methods
IL220283A0 (en) 4-oxo-ih-quinoline-3- carboxamides, compositions comprising the same and uses thereof
EP2518147A4 (en) DIACYLGLYCEROLACYLTRANSFERASEGEN AND ITS USE
EP2492276A4 (en) METAL COMPLEX, POLYMER, AND MEMBER OBTAINED THEREFROM
ZA201204718B (en) Substituted piperidines that increase p53 activity and the uses thereof
GB0902052D0 (en) Polymers,composition and use
ZA201109034B (en) Aminopyrrolidinone derivatives and uses thereof
EP2445067A4 (en) COMPOSITION FOR FILLING THE DISCHARGE GAP AND ELECTROSTATIC DISCHARGE PROTECTION
SG10201400577QA (en) Improved microcapsules, and production thereof
EP2470499A4 (en) NEW COLCHICINE DERIVATIVE AND METHOD AND USES THEREOF
AP3066A (en) Heterocyclic sulfonamides, uses and pharmaceuticalcompositions thereof
GB201103931D0 (en) Printable composition, method and uses thereof
IL219243A (en) History of 5-hydroxypyrimidine-4-carboxamide, preparations containing them and their uses
HK1178526A1 (en) Tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof 8--7-
EP2438173A4 (en) BIOMATERIALS, COMPOSITIONS AND METHODS
IL216828A0 (en) Styryl-triazine derivatives, compositions comprising the same and uses thereof
GB0912744D0 (en) Methods and uses
IL216701A (en) Adhesives, their production and application
HK1177452A1 (en) Fluoro-substituted 2-aryl-3,5-dicyano-4-indazolyl-6-methyl-1,4- dihydropyridines and uses thereof 2--3,5--4--6--1,4-
IL213996A0 (en) Sulfamoyl-phenyl-ureido-benzamidine derivatives, compositions comprising the same and uses thereof
GB0902875D0 (en) Medicaments,uses and methods
GB0903145D0 (en) Medicaments uses and methods

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20191108